EVEROLIMUS-ELUTING XIENCE PRIME/X PEDITION VERSUS ZOTAROLIMUS-ELUTING RESOLUTE INTEGRITY STENTS IN PATIENTS WITH DIABETES MELLITUS AND SMALL VESSEL DISEASE: AN ANALYSIS FROM THE 2-YEAR PROSPECTIVE RANDOMIZED COPERES STUDY

This study sought to compare Xience Prime/ X-pedition everolimus-eluting stents (EES) versus Resolute Integrity zotarolimus-eluting stents (ZES) in terms of patient- or stent-related clinical outcomes with DM or small vessel disease. PCI of small vessels or patient with DM is limited by an increased